Publication details
4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Patent |
| MU Faculty or unit | |
| Publisher | Canadian Intellectual Property Office |
| State | Canada |
| Patent's number | CA3085967 |
| Web | https://worldwide.espacenet.com/patent/search/family/061837684/publication/CA3085967C?q=CA3085967C |
| Description | The present invention relates to novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds which are useful in the treatment of lymphomas, leukaemias, and solid tumors. |